Alcon Sues Over Alleged Eye Drop Patent Infringement

By Adam Lidgett (April 27, 2022, 6:33 PM EDT) -- The maker of the Pataday eye allergy treatment has launched a patent infringement lawsuit in Delaware federal court challenging a rival's bid to get the U.S. Food and Drug Administration to approve a generic version of the treatment.

In a Wednesday complaint, Alcon Inc. and Alcon Laboratories Inc. asked for an injunction that would bar Somerset Therapeutics, Somerset Pharma and Odin Pharmaceuticals from selling a proposed generic version of Alcon's Pataday.

Specifically, Alcon is fighting an abbreviated new drug application, or ANDA, that Somerset filed with the FDA to try and get approval for a generic version of Pataday Once Daily,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!